Total Payments
$1,035
2023 Payments
$273.23
Companies
8
Transactions
14
Medicare Patients
4,947
Medicare Billing
$444,174
Payment Breakdown by Category
Food & Beverage$1,035 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,035 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $213.56 | 3 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $173.66 | 2 | $0 (2019) |
| GlaxoSmithKline, LLC. | $143.46 | 3 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $129.23 | 2 | $0 (2018) |
| UROVANT SCIENCES INC | $124.99 | 1 | $0 (2022) |
| Amgen Inc. | $120.77 | 1 | $0 (2019) |
| Mylan Specialty L.P. | $110.91 | 1 | $0 (2023) |
| Abbott Laboratories | $18.86 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $273.23 | 5 | GlaxoSmithKline, LLC. ($143.46) |
| 2022 | $124.99 | 1 | UROVANT SCIENCES INC ($124.99) |
| 2020 | $123.38 | 1 | Novo Nordisk Inc ($123.38) |
| 2019 | $193.77 | 3 | Amgen Inc. ($120.77) |
| 2018 | $308.92 | 3 | Janssen Pharmaceuticals, Inc ($118.08) |
| 2017 | $11.15 | 1 | Janssen Pharmaceuticals, Inc ($11.15) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 07/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2023 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $110.91 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/24/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Diabetes Care | ||||||
| 11/10/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Urology | ||||||
| 01/29/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $123.38 | General |
| Category: Obesity | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $61.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/20/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Diabetes | ||||||
| 02/11/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $120.77 | General |
| Category: Bone Health | ||||||
| 12/10/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $118.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/07/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $112.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $78.35 | General |
| Category: Diabetes | ||||||
| 09/13/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,165 | 1,534 | $245,752 | $114,125 |
| 2022 | 17 | 1,478 | 1,805 | $313,003 | $121,026 |
| 2021 | 19 | 1,296 | 1,651 | $296,073 | $120,824 |
| 2020 | 17 | 1,008 | 1,251 | $239,677 | $88,200 |
Total Patients
4,947
Total Services
6,241
Medicare Billing
$444,174
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 269 | 510 | $92,700 | $41,853 | 45.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 226 | 226 | $55,151 | $28,232 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 180 | 251 | $34,383 | $13,694 | 39.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 179 | 179 | $30,246 | $13,474 | 44.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 30 | 30 | $17,108 | $8,463 | 49.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 29 | 29 | $3,625 | $2,086 | 57.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,020 | $1,826 | 36.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $1,386 | $1,233 | 89.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $1,125 | $910.16 | 80.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 50 | 50 | $2,150 | $878.50 | 40.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $1,386 | $833.91 | 60.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 42 | 55 | $593.00 | $336.05 | 56.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 16 | 16 | $304.00 | $152.32 | 50.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 14 | 14 | $252.00 | $71.12 | 28.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 19 | $107.00 | $41.80 | 39.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 54 | $216.00 | $39.70 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 268 | 505 | $124,065 | $39,365 | 31.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 245 | 245 | $65,000 | $30,688 | 47.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 239 | 240 | $47,648 | $18,614 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 184 | 253 | $41,967 | $13,495 | 32.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 76 | 76 | $7,740 | $5,206 | 67.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 23 | 23 | $4,870 | $3,034 | 62.3% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 12 | 12 | $5,127 | $2,740 | 53.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 79 | 79 | $2,958 | $2,209 | 74.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 14 | $5,240 | $2,088 | 39.8% |
About Dr. Dean Bailey, MD
Dr. Dean Bailey, MD is a Family Medicine healthcare provider based in Van Wert, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1780704445.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dean Bailey, MD has received a total of $1,035 in payments from pharmaceutical and medical device companies, with $273.23 received in 2023. These payments were reported across 14 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,035).
As a Medicare-enrolled provider, Bailey has provided services to 4,947 Medicare beneficiaries, totaling 6,241 services with total Medicare billing of $444,174. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Van Wert, OH
- Active Since 03/29/2007
- Last Updated 05/21/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1780704445
Products in Payments
- FARXIGA (Drug) $173.66
- XARELTO (Drug) $129.23
- AREXVY (Drug) $125.00
- GEMTESA (Drug) $124.99
- Saxenda (Drug) $123.38
- Prolia (Biological) $120.77
- Yupelri (Drug) $110.91
- Ozempic (Drug) $78.35
- FREESTYLE LIBRE 3 (Device) $18.86
- TRELEGY ELLIPTA (Drug) $18.46
- Tresiba (Drug) $11.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Van Wert
Dr. Matthew Miller, M.d, M.D
Family Medicine — Payments: $1,875
Family Medicine $1,875
Dr. Robert Adams, M.d, M.D
Family Medicine — Payments: $1,256
Family Medicine $1,256
Dr. Rebecca Adams, Md, MD
Family Medicine — Payments: $1,086
Family Medicine $1,086
Dr. Jacob Jones, M.d, M.D
Family Medicine — Payments: $737.89
Family Medicine $737.89
Kristen Pollock, D.o, D.O
Family Medicine — Payments: $647.35
Family Medicine $647.35
Dr. Adam Houg, Md, MD
Family Medicine — Payments: $491.31
Family Medicine $491.31